KeyBank National Association’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,690
Closed -$258K 1210
2025
Q1
$258K Buy
8,690
+1,425
+20% +$54.3K ﹤0.01% 1024
2024
Q4
$288K Buy
+7,265
New +$275K ﹤0.01% 1011
2021
Q2
Sell
-4,084
Closed -$220K 1089
2021
Q1
$220K Sell
4,084
-182
-4% -$10.5K ﹤0.01% 1008
2020
Q4
$209K Buy
+4,266
New +$198K ﹤0.01% 993

Other funds holding VCYT

KeyBank National Association's VCYT Position: Q2 2025 in Review

KeyBank National Association sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 8,690 shares — an estimated $258K sold.

KeyBank National Association first reported a position in VCYT in Q4 2020 and held it in 4 quarters. The position peaked at $288K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • KeyBank National Association reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • KeyBank National Association sold 8,690 Veracyte shares in Q2 2025, an estimated $258K.
  • KeyBank National Association first reported a position in Veracyte in Q4 2020 and held it in 4 quarters.
  • KeyBank National Association's Veracyte position peaked at $288K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on KeyBank National Association's 13F filing for Q2 2025, filed 4 Aug 2025.